Role And Enteral Feeding Hierarchy

  • Mother's Own Milk (MOM) is the primary nutritional choice for all neonates.
  • When mother's own milk is unavailable, insufficient, or contraindicated, pasteurized Donor Human Milk (DHM) from an accredited milk bank is the universally recommended first alternative for very low birth weight (VLBW) and preterm infants.
  • Preterm formula is the least preferred alternative due to an increased risk of serious gastrointestinal complications.
  • The feeding hierarchy for preterm infants is:
    1. Mother's own fresh preterm milk.
    2. Pasteurized donor human milk from an accredited milk bank.
    3. Specialized preterm infant formula.

Clinical Evidence (Donor Milk vs Preterm Formula)

  • Reduction in Necrotizing Enterocolitis (NEC):
    • Cochrane systematic reviews show that feeding donor human milk to VLBW infants reduces the incidence of necrotizing enterocolitis (NEC) by approximately 50% compared to preterm formula (RR 0.53, 95% CI 0.37–0.76).
    • The Number Needed to Treat (NNT) to prevent one case of NEC with donor milk is approximately 20 infants.
  • Infection and Gut Maturation:
    • Promotes early intestinal mucosal barrier closure, stabilizes gut microcirculation, and establishes an anaerobic protective microbiome.
    • Significantly decreases episodes of late-onset sepsis and feeding intolerance compared to formula.
  • Growth Differences and Need for Fortification:
    • Unfortified donor milk often has a lower protein and caloric content than fresh preterm milk because milk donors are predominantly mothers of older, mature term infants.
    • While donor milk protects against NEC, infants fed unfortified donor milk exhibit slower rates of weight gain and linear growth compared to formula.
    • Human Milk Fortification (HMF) is mandatory once enteral feeds reach 100 mL/kg/day in infants <1.8 kg or <34 weeks gestation.

Processing Methods (Holder vs Novel Technologies)

Processing ParameterHolder Pasteurization (HoP)High-Temperature Short-Time (HTST)High-Pressure Processing (HPP)
Temperature / Condition62.5°C for 30 minutes72°C for 5 to 15 seconds300 to 600 MPa at room temperature
Pathogen InactivationInactivates CMV, HIV, HTLV, Hepatitis, bacteriaInactivates viral and bacterial pathogensEliminates vegetative bacteria and viruses
Bile Salt-Stimulated LipaseDestroyed (0% activity retained)Partially preservedInactivated
Secretory IgA (sIgA)60% to 80% preserved80% to 90% preserved85% to 95% preserved
Lactoferrin And LysozymeMarked loss (50% to 90% reduction)Better preservedSignificantly preserved
Human Milk Oligosaccharides (HMOs)100% Thermostable (fully preserved)100% Thermostable100% Preserved
Current Practice StatusUniversal global standard of careResearch and pilot centersEmerging experimental technology

National Guidelines In India (CLMC Structure)

The Ministry of Health and Family Welfare (MoHFW) guidelines established a standardized three-tier network:

  • Comprehensive Lactation Management Centre (CLMC):
    • Located at tertiary care medical colleges and advanced referral hospitals.
    • Equipped with full processing infrastructure: laminar flow hoods, automated Holder pasteurizers, -20°C deep freezers, milk analyzers, and microbiology testing facilities.
    • Collects, screens, pasteurizes, tests, stores, and dispenses donor milk.
  • Lactation Management Unit (LMU):
    • Located at District Hospitals and Special Newborn Care Units (SNCUs).
    • Collects expressed mother's own milk, stores milk, and receives pasteurized donor milk from the parent CLMC.
  • Lactation Support Unit (LSU):
    • Located at sub-district hospitals and Community Health Centres.
    • Focuses on individual lactation counseling, kangaroo mother care advocacy, and early expression support.

Donor Screening And Microbiological Standards

Donor Eligibility

  • Healthy lactating women who have surplus breast milk after fully nursing their own biological infant.
  • Voluntary, non-remunerated, altruistic donation.
  • Must test negative on serological screening for: HIV-1 and 2, HBsAg, Anti-HCV, and Syphilis (VDRL).
  • Absolute contraindications: Active untreated tuberculosis, localized herpes simplex lesions on the breast, systemic infections, and use of medications contraindicated during breastfeeding.

Microbiological Standards

  • Pre-Pasteurization Baseline: Total viable bacterial colony count must be <100,000 CFU/mL; zero Staphylococcus aureus or Enterobacteriaceae allowed.
  • Post-Pasteurization Verification: Must yield complete sterility (zero bacterial growth) after 48 hours of incubation before the batch is released for clinical use.
  • Storage: Stored at -20°C for up to 3 to 6 months. Once thawed at 4°C, it must be consumed within 24 hours and must never be refrozen.

Human Milk Fortification (HMF)

  • Standard Fortification: Fixed ratio of fortifier sachets added to donor milk (1 sachet per 25 to 50 mL of milk); assumes standard baseline milk protein, which often under-delivers protein.
  • Adjustable Fortification: Fortification titrated based on metabolic response using Blood Urea Nitrogen (BUN) as a biomarker. Target BUN is 9 to 14 mg/dL; if BUN is <9 mg/dL, additional protein is added.
  • Targeted Fortification: Bedside mid-infrared milk analyzers quantify exact protein, fat, and carbohydrate levels in donor milk batches, and customized modular protein and energy packets are added to achieve target intakes.